Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Lung-Fluid-Guided Hydration to Protect Kidneys in Older Adults Having Heart Artery Procedures

Tests fluid dosing guided by a lung fluid monitor in older adults with kidney problems.

Plain-language title generated from the registry record
Registry title: Hydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Chinese PLA General HospitalBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chinese PLA General Hospital
Trial code
NCT07394959
Record updated
6 February 2026
Original description
Explore the effectiveness and safety of tailored hydration guided by lung water index monitor system for prevention of acute kidney injury after percutaneous coronary intervention for elderly patients with renal insufficiency.Read full original descriptionShow less

Clinical Study on Tailored Hydration by Remote Dielectric Sensing System to Prevent Acute Renal Injury in Elderly Patients With Renal Insufficiency After Coronary Angiography

Explore the effectiveness and safety of tailored hydration guided by lung water index monitor system for prevention of acute kidney injury after percutaneous coronary intervention for elderly patients with renal insufficiency.

Inclusion: Age ≥ 60 years; Patients with unstable angina pectoris are scheduled for percutaneous coronary intervention;; Patients with chronic renal disease (estimated glomerular filtration rate < 90 ml/min); Sign the informed consent form.

Exclusion: 1. Acute decompensated severe heart failure or cardiogenic shock; 2. Malignant tumors, severe renal failure (estimated glomerular filtration rate < 30 ml/min); 3. Respiratory failure; 5. Have allergic to contrast medium; 4. Used contrast media within one week.

ClinicalTrials.gov NCT07394959